EUVIMEDEUVIMED entdecken
Crossref

KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation

Tao Ni, Ru-Hua Zhao, Jing-Fang Wu, Chao-You Li, Gang Xue, Xu Lin

Biochemical Genetics · 2024

DOI: 10.1007/s10528-024-10679-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Genetics, 2024. Verfasst von Tao Ni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China. Hauptthemen laut MEDLINE: Kallikreins, Thyroid Cancer, Papillary, Thyroid Neoplasms, Computational Biology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Zhangjiakou City Municipal Science and Technology Plan Self-financing Projects, Scientific Research Project for Higher Education Institutions of Hebei Provincial Education Department, Research Project of Hebei North University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite many studies on papillary thyroid carcinoma (PTC) in the past few decades, some critical and significant genes remain undiscovered. To explore genes that may play crucial roles in PTC, a detailed analysis of the expression levels, mutations, and clinical significance of Kallikrein-related peptidases (KLKs) family genes in PTC was undertaken to provide new targets for the precise treatment of the disease. A comprehensive analysis of KLK family genes was performed using various online tools, such as GEPIA, Kaplan-Meier Plotter, LinkedOmics, GSCA, TIMER, and Cluego. KLK7, KLK10, and KLK11 were critical factors of KLK family genes. Then, functional assays were carried out on KLK7/10/11 to determine their proliferation, migration, and invasion capabilities in PTC. The mRNA expression levels of KLK7, KLK10, KLK11, and KLK13 were significantly elevated in thyroid carcinoma, while KLK1, KLK2, KLK3 and KLK4 mRNA levels were decreased compared to normal tissues. Correlations between KLK2/7-12/15 expression levels and tumor stage were also observed in thyroid carcinoma. Survival analysis demonstrated that KLK4/5/7/9-12/14 was associated with overall survival in patients with thyroid cancer. Not only were KLK genes strongly associated with cancer-related pathways, but also KLK7/10/11 was associated with immune-cell infiltration. Finally, silencing KLK7/10/11 impaired human papillary thyroid carcinoma cells' growth, migration ability, and invasiveness. The increased expression of KLK7, KLK10, and KLK11 may serve as molecular markers to identify PTC patients. KLK7, KLK10, and KLK11 could be potential prognostic indicators and targets for precision therapy against PTC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KallikreinsThyroid Cancer, PapillaryThyroid NeoplasmsComputational BiologyHumansCell MovementGene Expression Regulation, NeoplasticMaleFemaleCell Line, TumorCell ProliferationBiomarkers, Tumor

Stichwörter der Autor:innen

FunctionKallikrein-related peptidasesPapillary thyroid carcinomaTCGA

Substanzen

KallikreinsKLK7 protein, humanKLK10 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China.
  • Department of Morphology Laboratory, Hebei North University, Zhangjiakou, 075000, China.
  • Department of Otorhinolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China. xgwjf@163.com.
  • Department of Morphology Laboratory, Hebei North University, Zhangjiakou, 075000, China. 305461101@qq.com.

Förderung

  • Zhangjiakou City Municipal Science and Technology Plan Self-financing Projects
  • Scientific Research Project for Higher Education Institutions of Hebei Provincial Education Department
  • Research Project of Hebei North University

Zitieren

APA

Ni, T., Zhao, R. H., Wu, J. F., Li, C. Y., Xue, G., & Lin, X. (2024). KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation. Biochemical Genetics. https://doi.org/10.1007/s10528-024-10679-8

Vancouver

Ni T, Zhao RH, Wu JF, Li CY, Xue G, Lin X. KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation. Biochemical Genetics. 2024. doi:10.1007/s10528-024-10679-8

BibTeX
@article{Ni2024,
  author = {Ni, Tao and Zhao, Ru-Hua and Wu, Jing-Fang and Li, Chao-You and Xue, Gang and Lin, Xu},
  title = {KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation},
  journal = {Biochemical Genetics},
  year = {2024},
  doi = {10.1007/s10528-024-10679-8}
}
Kostenlos starten →